Replies to post #149372 on Cytodyn Inc (CYDY)

[treedonkey24]

Most definitely! We're probably looking at $20ish any day now. It will quickly move up from there once MORE people see all the other trials/indications that will quickly become approved.

[portage1066]

You got it all wrong. The trial was a failure. No way they hold back on positive data.

NP heightens the risk of lawsuits against the company each day he holds back data that all shareholders know he has. Only reason to hold back on the data is if the trial failed to meet its endpoints.

Each day that goes by should heighten your concern that NP is trying to dodge the consequences of a failed trial.

[Mohave]

Until then, it sure is boring us to death...:-)

[Bill_ENG]

Based on the EINDs that happened last Spring I agree with you that the data has to be spectacular.

Nothing published anywhere to show Covid-19 patients got worse on Leronlomab.

[Leronlimab4DaWin]

The eIND for Mild-to-moderate was disclosed on xmas eve at 8pm from a CD10 trial that was concluded in the summer!!!